NFKB1 and colitis: In addition, Toll-like receptor 4 (TLR4), one of the upstream signaling pathways of NF-kB, was blocked by RA administration to reduce inflammation via a competitive interaction with TLR4 at the binding sites of Arg-264 residue in a disease-related colitis mouse model [56].